Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
20.65
+0.31 (1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $529.52 million as of December 20, 2024. Its market cap has increased by 42.67% in one year.
Market Cap
529.52M
Enterprise Value
247.89M
1-Year Change
42.67%
Ranking
Category
Stock Price
$20.65
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $529.52M, an increase of 138.88%. That is a compound annual growth rate of 110.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 529.52M | -0.54% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 542.66M |
| CorMedix | 538.21M |
| Phathom Pharmaceuticals | 534.71M |
| Astria Therapeutics | 533.30M |
| Pacific Biosciences of California | 528.56M |
| Mind Medicine (MindMed) | 514.42M |
| Terns Pharmaceuticals | 513.88M |
| Mereo BioPharma Group | 509.61M |